Council of Scientific and Industrial Research

University of Florida Research Foundation, Incorporated

Rakesh Maurya

Ghulam Nabi Qazi

Abhishek Kumar Singh

Sukhdev Swami Handa

Ashwani Kumar

Naresh Kumar Satti

Bal Krishan Chandan

Girish Kumar Jain

Bupinder Singh Jaggi

Naibedya Chattopadhyay

Ritu Trivedi

Lila Ram Manahas

Lila Ram Manhas

Rajinder Singh

Bal Krishnan Kapahi

Krishan Avtar Suri

Ajit Kumar Saxena

Om Parkash Suri

Anamika Khajuria

Bal Krishan Kapahi

Gulam Nabi Qazi

Prabhat Ranjan Mishra

Sabyasachi Sanyal

Avinash Kumar

Divya Singh

Arun Kumar Trivedi

Anpurna Kaul

Asha Bhagat

Sudhir Kumar

Jiaur Rahaman Gayen

Nidhi Singh

Naresh Mittapelly

Kamal Ram Arya

Vikram Khedgikar

Sulekha Adhikary

Kurt Konigsberger

Lakshmi Manickavasagam

Dharmendra Choudhary

Jyoti Gautam

Sherita D McLamore

Geetanjali Mishra

Tomas Hudkicky

Om Parkash Gupta

Usha Zutshi

Sarang Bani

Krishnan Avtar Suri

Deepa Singh

Gaurav Swarnkar

Preety Dixit

Shelendra Pratap Singh

Wahajuddin

Naseer Ahmad

Kapil Dev

Shailendra Kumar Dhar Dwivedi

Manisha Yadav

Jay Sharan Mishra

Preeti Rawat

Kunal Sharan

Jawed Akhtar Siddiqui

Deepak Mundkinajeddu

Smrati Bhadauria

Rashmi Kumari

Parvez Mohammad Khan

Kainat Khan

Devendra Pratap Mishra

Sharad Sharma

Ram Arya Kamal

Sheelendra Pratap Singh

The present invention relates to bioactive fractions and compounds fromfor the prevention or treatment of osteo-health related disorders. The present invention relates in the field of pharmaceutical composition that provides new plant extracts, their fractions and pure compound isolated from natural sources that are useful for the prevention and/or treatment of various medical indications associated with estrogen dependent or independent diseases or syndromes or disorders preferably in the prevention or treatment of estrogen dependent or independent diseases or syndromes or disorders caused in humans and animals, and achievement of peak bone mass during skeletal growth and health in humans and animals. Particularly the present invention further relates to the processes for the preparation of biologically active extracts, fractions, and isolation of pure compounds, fromplant from the family Fabaceae their pharmaceutically acceptable salts and compositions of the principal aspect of the present invention.

[object Object]

The present invention relates to a formulation ofuseful for the prevention or treatment of osteo-health related disorders. The present invention relates to the field of pharmaceutical formulation that provides extract, fractions, pure compound isolated from natural sources and formulation thereof useful for the prevention and treatment of various medical indications. Further, this invention relates to conditions associated with estrogen dependent or independent diseases (primary/secondary osteoporosis) or syndromes or disorders preferably relating to cartilage such as osteoarthritis caused in humans and animals. Furthermore, this invention relates to achievement of peak bone mass during skeletal growth and health in humans and animals. Particularly, the present invention relates to the processes for the preparation of biologically active extracts, fromfrom the family Amaranthaceae their pharmaceutically acceptable excepients and compositions of the principal aspect of the present invention.

Formulation for the prevention and treatment of bone related disorders

The present invention provides a flavonol compound and a bioactive extract/fraction fromuseful for the management or prevention or treatment of bone disorders. Said extract/fraction comprising marker compounds of general formula 2, K058: R&#x2550;R&#x2550;OH K012: R&#x2550;R&#x2550;OH, 2,3 double bond K068: R&#x2550;R&#x2550;H KIOOi R&#x2550;OH, R&#x2550;H mula 2 Wherein the marker compounds K012, K058, K068, K1OO ranges 6.7-12%, 1.7-4.5%, 0.6-1.2%, 1.7-4.5% respectively in alcoholic extract and a process of extraction thereof. According to another aspect of the invention provides a pharmaceutical composition comprising the said compound. The present invention further provides a method of treating bone disorders by administering the pharmaceutical composition by oral, intravenous, subcutaneous, intra-peritoneal or intramuscular route. 

The present invention relates to a process of isolation of bioactive eupalitin (3-O-O-D-galactopyranoside) of formula 1 possessing anti-osteoporosis activity by extraction of powdered leaves of, with better yield:

Process for isolation of eupalitin from Boerhavia diffusa

The present invention relates to a composition useful for hepatoprotection, said composition comprising polar extract of plantand/or fractions of the said extract, and optionally pharmaceutically acceptable additives and a method of producing said composition and also a method of treating a subject using said composition.

Composition useful as hepatoprotectants comprising extract of plant Cryptolepis buchanani and a method thereof

The present invention relates to a novel compound 8-(C-&bgr;-D-glucopyranosyl)-7,3&prime;,4&prime;-trihydroxyflavone, isolated from useful in the treatment of diabetes. The present invention also relates to a method for the preparation of the compound and to the uses thereof.

8-(C-&bgr;-D-glucopyranosyl)-7, 3', 4'-trihydroxyflavone, process of isolation thereof, pharmaceutical composition and method for the treatment of diabetes

The present invention relates to a composition useful for hepatoprotection, said composition comprising polar extract of plant and/or fractions of the said extract, and optionally pharmaceutically acceptable additives and a method of producing said composition and also a method of treating a subject using said composition.

Glucopyranoside and process of isolation thereof from pterocarpus marsupium pharmaceutical composition containing the same and use thereof

Glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof

Pharmaceutical composition and a method useful for treating immunodeficiency in animals or human beings, said composition comprising effective amount of the extract obtained from any part of plant either as such or its individual constituents singly or in composition with each other, optionally associated with pharmaceutically acceptable additives.

Pharmaceutical composition comprising extract from plant Cryptolepis buchanani for treating immunodeficiency

Disclosed are novel pancratistatins and methods for their total asymmetric synthesis. In particular embodiments, processes for the total asymmetric synthesis of (+)-pancratistatin, (-)-pancratistatin, (+)-7-deoxypancratistatin, (-)-7-deoxypancratistatin, truncated pancratistatins, and related derivatives are provided.

Pancratistatins and processes for their production

Growing community of inventors

Jammu, India

Rakesh Maurya